Relapsed/Refractory Acute Myeloid Leukemia

20 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Relapsed/Refractory Acute Myeloid Leukemia

Record	Firm	Date
LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia (NCT05518357)	Hebei Yanda Ludaopei Hospital	2022-06-24
Long-Term Follow-up Study (NCT05332054)	Caribou Biosciences, Inc.	2022-03-16
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Max-40279-01 in Combination With Azacitidine (AZA) in Patients With Myelodysplastic Syndrome (MDS) or Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) (NCT05061147)	Maxinovel Pty., Ltd.	2021-09-16
A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies (NCT03886831)	Prelude Therapeutics	2019-02-11
Efficacy/Safety of CPI-613 in Combination With HD Cyt. and Mito. vs HD Cyt. and Mito. in Older Patients With R/R AML (NCT03504410)	Cornerstone Pharmaceuticals	2018-11-12
Arsenic Trioxide With Cyclophosphamide in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT03318016)	University of Colorado, Denver	2017-12-15
Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (NCT03190278)	Cellectis S.A.	2017-06-19
A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid Leukemia (NCT02665143)	Yale University	2016-07-21
Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation (NCT01806116)	The First Affiliated Hospital of Soochow University	2009-09-01
US Expanded Access Program for Magrolimab in Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT05627466)	Gilead Sciences

Track Relapsed/Refractory Acute Myeloid Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.